Login / Signup

VPAC1 and VPAC2 receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.

Diana Cunha-ReisJoaquim Alexandre RibeiroRodrigo F M de AlmeidaAna M Sebastião
Published in: British journal of pharmacology (2017)
Our results show that VPAC1 and VPAC2 VIP receptors have opposing actions on GABA release from hippocampal nerve terminals through activation of different transduction pathways. As VPAC1 and VPAC2 receptors are located in different layers of Ammon's horn, our results suggest that these VIP receptors underlie different modulation of synaptic transmission to pyramidal cell dendrites and cell bodies, with important consequences for their possible therapeutic application in the treatment of epilepsy.
Keyphrases
  • single cell
  • cell therapy
  • stem cells
  • temporal lobe epilepsy
  • neuropathic pain
  • mesenchymal stem cells
  • spinal cord injury
  • replacement therapy